Published in Kidney Int on February 26, 2014
Podometrics as a Potential Clinical Tool for Glomerular Disease Management. Semin Nephrol (2015) 0.83
Endothelin-1 and the kidney: new perspectives and recent findings. Curr Opin Nephrol Hypertens (2016) 0.81
Quantitative podocyte parameters predict human native kidney and allograft half-lives. JCI Insight (2016) 0.76
Comparison of blood and urine nephrin levels in preeclampsia and intrauterine growth retardation. Pak J Med Sci (2016) 0.75
Differential regional fatty acid distribution in normotensive and preeclampsia placenta. BBA Clin (2015) 0.75
Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia. Exp Ther Med (2016) 0.75
Hypertensive disorders in pregnancy. World J Nephrol (2016) 0.75
Influence of random urine albumin-creatinine ratio of pregnant women with hypertension during the gestation period on perinatal outcome. Exp Ther Med (2016) 0.75
Preeclampsia and ESRD: The Role of Shared Risk Factors. Am J Kidney Dis (2016) 0.75
Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases. Life Sci (2016) 0.75
The role of the podocyte in preeclampsia. Clin J Am Soc Nephrol (2014) 0.75
Relationship of Liver X Receptors α and Endoglin Levels in Serum and Placenta with Preeclampsia. PLoS One (2016) 0.75
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (1999) 11.37
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol (2000) 11.11
VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med (2008) 9.87
Notch signaling is essential for vascular morphogenesis in mice. Genes Dev (2000) 6.88
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol (2005) 4.79
Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol (1986) 4.65
Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol (1997) 4.43
Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome) Am J Obstet Gynecol (1993) 4.27
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol (2003) 3.51
Regulation of human placental development by oxygen tension. Science (1997) 3.49
The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (1999) 3.46
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem (2003) 3.36
Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol (1996) 3.34
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation (2011) 3.33
Preeclampsia and the risk of end-stage renal disease. N Engl J Med (2008) 3.31
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest (1973) 3.08
The therapeutic potential of carbon monoxide. Nat Rev Drug Discov (2010) 3.03
Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development (1998) 2.92
Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG (2012) 2.91
Recent Insights into the pathogenesis of pre-eclampsia. Placenta (2002) 2.91
Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet (2005) 2.88
Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int (2007) 2.87
A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol (1994) 2.56
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension (2007) 2.53
Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med (2001) 2.42
Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta (2009) 2.37
Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation (2007) 2.35
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA (1999) 2.34
Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation (2013) 2.34
Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ (2013) 2.34
Avosentan for overt diabetic nephropathy. J Am Soc Nephrol (2010) 2.32
Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int (2011) 2.28
Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev (2007) 2.07
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension (2009) 2.00
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation (2012) 1.88
Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett (1996) 1.87
Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia. Reprod Sci (2009) 1.87
Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension (2008) 1.78
Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension (2013) 1.76
Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol (2007) 1.75
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension (2008) 1.72
Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol (2004) 1.69
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension (2008) 1.65
Canonical and non-canonical Notch ligands. Curr Top Dev Biol (2010) 1.62
A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv (2011) 1.58
Maternal exposure to moderate ambient carbon monoxide is associated with decreased risk of preeclampsia. Am J Obstet Gynecol (2012) 1.56
Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol (2007) 1.54
Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension (2001) 1.51
Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens (Greenwich) (2013) 1.48
Familial factors in the association between preeclampsia and later ESRD. Clin J Am Soc Nephrol (2012) 1.47
Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol (2002) 1.47
Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron (2001) 1.41
Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol (2008) 1.41
Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant (2007) 1.37
Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension (1996) 1.31
Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron Clin Pract (2009) 1.31
Redefining preeclampsia using placenta-derived biomarkers. Hypertension (2013) 1.30
A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol (2012) 1.24
Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis (2010) 1.23
Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol Dial Transplant (2008) 1.19
Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia. Am J Physiol Renal Physiol (2012) 1.17
A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia. Development (2011) 1.15
Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide (2000) 1.12
Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Hypertension (2004) 1.08
Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gend Med (2011) 1.07
eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. J Am Soc Nephrol (2012) 1.05
Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol (2000) 1.05
Distribution of Notch protein members in normal and preeclampsia-complicated placentas. Cell Tissue Res (2007) 1.04
Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol (2011) 1.04
Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens (2008) 1.03
Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia. Eur J Obstet Gynecol Reprod Biol (2012) 0.99
Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci U S A (2013) 0.99
Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia. Reprod Sci (2011) 0.99
Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Pathol (2006) 0.98
Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension (2013) 0.98
Nitric oxide production with preeclampsia. Obstet Gynecol (1999) 0.98
Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol (1999) 0.97
STOX1 gene in pre-eclampsia and intrauterine growth restriction. BJOG (2007) 0.97
Quantitative polymerase chain reaction-based analysis of podocyturia is a feasible diagnostic tool in preeclampsia. Hypertension (2012) 0.96
Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse. FASEB J (2011) 0.96
Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension (2012) 0.96
Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats. Am J Hypertens (2009) 0.96
Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy. Am J Nephrol (2000) 0.96
Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon monoxide. J Pathol (2011) 0.95
Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients. J Pregnancy (2012) 0.95
Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia. Nephrol Dial Transplant (2012) 0.93
Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur J Hum Genet (2007) 0.92
Molecular genetics of preeclampsia and HELLP syndrome - a review. Biochim Biophys Acta (2012) 0.91
Distribution of Notch family proteins in intrauterine growth restriction and hypertension complicated human term placentas. Acta Histochem (2009) 0.91
Pharmacological knockout of endothelin ET(A) receptors. Life Sci (2003) 0.91
Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol (1996) 0.89
Renal involvement in preeclampsia: similarities to VEGF ablation therapy. J Pregnancy (2010) 0.88
End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol (2000) 0.87
Does elevated nitric oxide production enhance the release of prostacyclin from shear stressed aortic endothelial cells? Biochem Biophys Res Commun (1997) 0.87
Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol (2010) 0.85
Inhibitors of heme oxygenase reduce invasion of human primary cytotrophoblast cells in vitro. Placenta (2009) 0.84
Nitric oxide-endothelin-1 interaction in humans. J Appl Physiol (1985) (1997) 0.84
Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart (2015) 0.78